Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice

Author(s): Katayama S, Oda K, Ohgitani T, Hirahara T, Shimizu Y

Abstract

The influence of antigenic forms of Aujeszky's disease virus (ADV) and adjuvant types on the production of IgG subclass antibodies in mice was investigated. Particulate antigen, inactivated ADV, alone induced IgG1 and lower IgG2a antibody production, while the antigen adsorbed onto aluminum phosphate gel (alum) enhanced IgG1 antibody production but suppressed IgG2a antibody production as well as solubilized ADV antigen adsorbed onto alum. QS21 saponin purified from Quillaja saponaria promoted the production of IgG1 and IgG2a antibodies in a large extent against the both particulate and soluble antigens, while this saponin has strong hemolytic activity. Lablaboside F saponin isolated from Dolichos lablab without hemolytic activity, also induced the production of large IgG1 and little IgG2a antibody against both antigens. Oil-based adjuvant, ISA70 of water-in-oil type and ISA25 of oil-in-water type, increased IgG1 and IgG2a antibodies against the both soluble and particulate antigens, whereas a combination of ISA25 and soluble antigen reduced IgG2a antibody response. These results indicate that IgG1 antibody production was not suppressed by a combination of antigenic form and adjuvant type, however, IgG2a antibody production was influenced.

Similar Articles

Saponins as vaccine adjuvants

Author(s): Kensil CR

Advances in saponin-based adjuvants

Author(s): Sun HX, Xie Y, Ye YP

Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer

Author(s): Ragupathi G, Gardner JR, Livingston PO, Gin DY

Potential adjuvantic properties of innate immune stimuli

Author(s): Warshakoon HJ, Hood JD, Kimbrell MR, Malladi S, Wu WY, et al

Saponin adjuvants

Author(s): Dalsgaard K

Saponin

Author(s): Campbell JB, Peerbaye YA

Immunostimulating complexes (ISCOMs) for nasal vaccination

Author(s): Hu KF, Lövgren-Bengtsson K, Morein B

Antigen delivery systems

Author(s): Kersten G, Hirschberg H

Vaccine adjuvants revisited

Author(s): Aguilar JC, Rodríguez EG

QS-21 and QS-7: purified saponin adjuvants

Author(s): Kensil CR, Wu JY, Anderson CA, Wheeler DA, Amsden J

QS-21 structure/function studies: effect of acylation on adjuvant activity

Author(s): Liu G, Anderson C, Scaltreto H, Barbon J, Kensil CR

Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats

Author(s): Marciani DJ, Kensil CR, Beltz GA, Hung CH, Cronier J, et al.